Anetumab ravtansine | Interleukin Related interleukin-related.com

Product Name :
Anetumab ravtansine

Search keywords :
SPDB-DM4

drugId :
null

Target Vo:
Mesothelin

Target Vo Short Name :
MSLN

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Morphosys Ag

Active Company_Name :
Bayer AG

Active Indication_Name:
Peritoneal Neoplasms

In Active Indication_Name:
Lung Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
OGT Antibody
Cyclin B1 Antibody
Phospho-STAT3 (Tyr705) Antibody (YA146): Phospho-STAT3 (Tyr705) Antibody (YA146) is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Phospho-STAT3(Tyr705). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts